Mumbai: The United States Food and Drug Administration (FDA) has imposed an import alert, effectively a ban, on generic drugmaker Sun Pharmaceutical Industries Ltd`s plant in Gujarat.
An "import alert" results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices, according to the FDA website.
A spokesman for Sun, India`s biggest drugmaker by market value, was not available for comment.
The plant in Karkhadi in Gujarat makes both drug ingredients and formulations, according to Sun`s 2013 annual report.
Zee News App: Read latest news of India and world, bollywood news, business updates, cricket scores, etc. Download the Zee news app now to keep up with daily breaking news and live news event coverage.
